Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
299K
-
Shares change
-
+163K
-
Total reported value, excl. options
-
$1.53M
-
Value change
-
+$850K
-
Number of buys
-
3
-
Price
-
$5.02
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q4 2023
3 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q4 2023.
ImmunityBio, Inc. - COM (IBRX) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 299K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (13.3M shares), BlackRock Inc. (10.7M shares), STATE STREET CORP (9.47M shares), GEODE CAPITAL MANAGEMENT, LLC (3.38M shares), CREDIT SUISSE AG/ (1.53M shares), JPMORGAN CHASE & CO (1.42M shares), NORTHERN TRUST CORP (1.36M shares), GOLDMAN SACHS GROUP INC (1.28M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.14M shares), and BANK OF AMERICA CORP /DE/ (892K shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.